Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021

Salim Syed Maintained (BBIO) at Strong Buy with Increased Target to $86 on, Mar 4th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-86-on-mar-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Salim Syed of Mizuho, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $56 to $86 on, Mar 4th, 2021.

Salim has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Salim's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Salim


  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $83 on, Tuesday, February 9th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $44 on, Friday, December 4th, 2020